Gene and cell therapy firm Oxford Biomedica said on Monday it signed a new manufacturing agreement to help it scale up production of AstraZeneca’s potential COVID-19 vaccine to cater to demand in the United Kingdom and Europe.
Want to know more onOxford Biomedica inks agreement to boost UK supply of AstraZeneca’s COVID-19 vaccine
click here go to market news source. Market news summary from Reuters Market News.Author: …From -
click here go to market news source.
Market news summary from Reuters Market News.